FX Multitech IPO GMP Today, Price & Details

Listed SME (BSE)

FX Multitech IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details

SENTIMENT INDICATOR

🟢 BULLISH

80/100
BearishNeutralBullish
Why this rating:
  • ✓ Strong subscription at 21.0x
  • ✓ Strong financials (EPS ₹8.8, RoNW 36.5%)
  • ✓ Reasonable P/E ratio (14.4)
* Algorithm-based signal from GMP, subscription & financials. NOT investment advice.
Listing Price ₹123
Closing Price ₹129.20
Listing Gain +₹7 (+6.1%)
Profit Per Lot +₹8,460

About FX Multitech

FX Multitech is set to launch its Initial Public Offering (IPO) on the BSE SME platform, aiming to raise approximately ₹45 Cr. The company operates within the manufacturing sector, offering a range of products and services. This IPO represents a significant step for FX Multitech as it seeks to expand its operational scale and enhance its market presence. The issue is structured as a fresh issue, with a price band set between ₹110 and ₹116 per share, and a face value of ₹10 per share.

The company's recent financial performance showcases a revenue of ₹26.63 Cr and a Profit After Tax (PAT) of ₹2.35 Cr. This translates to an Earnings Per Share (EPS) of ₹8.84. The IPO is being offered at a P/E ratio of 14.43x, based on the upper end of the price band and its trailing EPS. The total issue size is ₹45 Cr, with a lot size of 1200 shares, meaning a minimum investment of ₹139,200 is required for retail investors.

FX Multitech appears to be positioning itself within a competitive landscape, and the proceeds from this IPO are earmarked for working capital requirements and general corporate purposes. This infusion of capital is expected to fuel the company's growth initiatives and strengthen its financial footing. The issue is managed by Oneview Corporate Advisors Pvt. Ltd., with MUFG Intime India Pvt. Ltd. serving as the registrar.

FX Multitech IPO — Investment Analysis

The valuation of FX Multitech IPO, with a P/E ratio of 14.43x, appears reasonable when benchmarked against its reported EPS of ₹8.84. This P/E suggests that investors are paying 14.43 times the company's earnings for each share, which is a crucial metric for assessing if the stock is overvalued or undervalued. The price band of ₹110 to ₹116 per share needs to be considered in the context of its NAV of ₹24.36, indicating a premium valuation. Investors will be keen to see if the company's future growth prospects justify this premium.

Financially, FX Multitech presents a mixed but promising picture. The company has reported a revenue of ₹26.63 Cr and a PAT of ₹2.35 Cr. Notably, its return ratios are quite strong, with a Return on Net Worth (RONW) of 36.54% and a Return on Capital Employed (ROCE) of 32.02%. These figures suggest efficient utilization of shareholder funds and capital. The EBITDA margin stands at 13.82%, indicating a healthy operational profitability. However, detailed historical financial data beyond these metrics is limited, which is typical for many SME IPOs.

Regarding growth prospects, the company's strong return ratios hint at a robust business model. The infusion of ₹45 Cr through this fresh issue is intended for working capital, which can support ongoing operations and potential expansion. However, risks associated with SME listings generally include higher volatility, limited liquidity, and potential challenges in scaling operations. The fact that this is a fresh issue with no Offer for Sale (OFS) component is a positive sign, as it means the capital raised will directly benefit the company's growth, rather than exiting shareholders cashing out.

The subscription data shows a significant interest from Qualified Institutional Buyers (QIBs), who have subscribed 20.95x, leading to an overall subscription of 20.95x. The absence of subscription from Retail and High Net-worth Individual (HNI) categories (marked as 0x) is unusual and warrants closer inspection. Typically, strong QIB interest indicates confidence from institutional investors, which can be a positive sentiment driver. However, the lack of retail and NII participation might suggest caution or a lack of awareness among these investor segments. This divergence in subscription patterns is something to watch closely.

Investors should consult a SEBI-registered financial advisor before making investment decisions.

Disclaimer: This analysis is auto-generated from publicly available financial data and should not be considered investment advice. Always consult a SEBI-registered financial advisor before making investment decisions.

FX Multitech IPO — Pros & Cons

Strengths

  • The company boasts impressive return ratios, with RONW at 36.54% and ROCE at 32.02%. These strong figures suggest that FX Multitech is effectively utilizing its capital and shareholder funds to generate profits, which is a key indicator of a well-managed and efficient business.
  • FX Multitech has demonstrated healthy profitability with an EBITDA margin of 13.82% on its revenue of ₹26.63 Cr. This indicates a good grip on operational costs and a solid ability to convert sales into earnings before interest, taxes, depreciation, and amortization.
  • The IPO is structured as a fresh issue amounting to ₹45 Cr, with no Offer for Sale (OFS) component. This means the entire proceeds will be utilized by the company for its business growth and working capital needs, rather than allowing existing shareholders to exit.
  • The company's Net Asset Value (NAV) stands at ₹24.36 per share. While the IPO price band is higher, a positive NAV provides a tangible book value backing for the company's shares.
  • A significant interest from QIBs, subscribing 20.95x, signals confidence from institutional investors. This could potentially lead to positive sentiment and demand for the stock post-listing, as institutional backing is often seen as a validation of a company's prospects.

Risks

  • The subscription figures show zero interest from Retail and NII categories (0x), while QIBs subscribed 20.95x. This unusual pattern might indicate a lack of broad market appeal or awareness among retail investors, potentially leading to lower demand post-listing.
  • The P/E ratio of 14.43x, based on an EPS of ₹8.84, appears relatively high when compared to the NAV of ₹24.36. This suggests that the market is pricing in future growth, and any failure to meet these expectations could put downward pressure on the stock price.
  • As an SME IPO, FX Multitech may face inherent risks such as lower trading volumes and potentially higher price volatility compared to mainboard companies. This could make it challenging for investors to exit their positions without impacting the stock price.
  • The provided data offers limited historical financial performance details, making it difficult to assess long-term revenue and profit trends thoroughly. Investors would ideally want to see a longer track record to gauge the company's resilience and growth trajectory.
  • The IPO's lot size is 1200 shares, requiring a minimum investment of ₹139,200 at the upper price band of ₹116. This is a substantial investment for retail investors, potentially limiting participation from smaller individual investors.

FX Multitech IPO Details

Company NameFX Multitech
IPO TypeSME
ExchangeBSE
Price Band₹110 - ₹116
Face Value₹10 per share
Lot Size1200 shares
Min Investment₹139,200
Total Issue Size₹45.00 Cr
RegistrarMUFG Intime India Pvt.Ltd.
Lead ManagerOneview Corporate Advisors Pvt.Ltd.
IPO StatusListed

FX Multitech IPO Dates

IPO Open Date TBA
IPO Close Date TBA
Allotment Date TBA
Listing Date 28 Sep 2026
Listing Price ₹123.05

FX Multitech IPO Subscription Status

Retail Individual 0.00x
NII / HNI 0.00x
QIB 20.95x
Total Subscription 20.95x

FX Multitech IPO Listing Performance

Issue Price
₹116
Listing Price
₹123
Closing Price
₹129.20
Listing Gain
+₹7 (+6.1%)
Profit Per Lot
+₹8,460

FX Multitech IPO listed on BSE on 28 Sep 2026 at ₹123, a premium of 6.1% over the issue price of ₹116. Investors who received allotment made a profit of ₹8,460 per lot (1200 shares) on listing day.

FX Multitech IPO — Key Highlights

  • FX Multitech has achieved a remarkable RONW of 36.54% and ROCE of 32.02%, indicating highly efficient capital utilization.
  • The company is seeking to raise ₹45 Cr through a fresh issue, with all proceeds intended for strengthening its working capital.
  • The IPO is priced at a P/E of 14.43x against an EPS of ₹8.84, offering a valuation point for investors to consider.
  • Qualified Institutional Buyers (QIBs) have shown strong interest, subscribing 20.95x to the issue.
  • The Net Asset Value (NAV) of the company stands at ₹24.36 per share.
  • FX Multitech reported a healthy EBITDA margin of 13.82% on its revenue of ₹26.63 Cr.

FX Multitech Financial Performance

Metric (₹ Cr) FY 2023* FY 2024* FY 2025 Q1 FY 2026
Revenue98.5968.52102.0126.63
Expenses92.6663.1289.6423.45
Net Income (PAT)4.584.189.552.35
Margin (%)4.65%6.10%9.36%8.82%

FX Multitech IPO Valuations & Key Metrics

Valuation Ratios

EPS₹8.84
P/E Ratio14.43x
NAV₹24.36
Current Ratio8,211.00
Debt/Equity8,211.000

Return Metrics

RONW (%)36.54%
ROCE (%)32.02%
EBITDA Margin13.82%

FX Multitech IPO Reservation / Allocation

Retail35%

FX Multitech IPO Anchor Investors

Bid DateComing soon
Shares OfferedComing soon
Anchor Portion (INR Cr.)Coming soon
Anchor lock-in period end date for 50% shares (30 Days)Coming soon
Anchor lock-in period end date for remaining shares (90 Days)Coming soon

FX Multitech IPO Lead Manager & Registrar

Book Running Lead Manager

Oneview Corporate Advisors Pvt.Ltd.

IPO Registrar

MUFG Intime India Pvt.Ltd.

📰 Latest News About FX Multitech

All IPO News →

⚖ Compare FX Multitech IPO

See how this IPO stacks up against similar ones — GMP, subscription, financials side-by-side.

Compare with another IPO →

FX Multitech IPO — Frequently Asked Questions

What is FX Multitech IPO GMP today?

As of today, the Grey Market Premium (GMP) for FX Multitech IPO is not available at this time. GMP values are updated daily based on grey market activity.

What is the price band and lot size of FX Multitech IPO?

FX Multitech IPO has a price band of ₹110 to ₹116 per equity share with a face value of ₹10. The minimum lot size is 1200 shares, requiring a minimum investment of ₹139,200 at the upper band.

What are the important dates for FX Multitech IPO?

FX Multitech IPO opens for subscription on TBA and closes on TBA. The shares are expected to list on BSE on 28 Sep 2026.

What is the investor category allocation in FX Multitech IPO?

The shares are reserved as follows — Qualified Institutional Buyers (QIB): 0.00%, Non-Institutional Investors (NII/HNI): 0.00%, and Retail Individual Investors: 35.06%.

How can I apply for FX Multitech IPO?

You can apply for FX Multitech IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment. The registrar for this IPO is MUFG Intime India Pvt.Ltd..

What is the subscription status of FX Multitech IPO?

FX Multitech IPO has been subscribed 20.95 times overall. Retail category: 0.00x, NII/HNI: 0.00x, QIB: 20.95x.

What is FX Multitech IPO price band and lot size?

The FX Multitech IPO is priced between ₹110 and ₹116 per share, with a face value of ₹10. The lot size for this IPO is 1200 shares. This means that the minimum investment required for retail investors is ₹139,200 (1200 shares x ₹116).

Is FX Multitech IPO worth investing in?

FX Multitech shows strong financial health with a RONW of 36.54% and an EBITDA margin of 13.82%. Its P/E of 14.43x is a key valuation metric to consider against its EPS of ₹8.84 and NAV of ₹24.36.

However, the unusual subscription pattern with zero retail and NII interest, coupled with the inherent risks of SME listings, warrants caution. Investors should carefully weigh the company's strengths against these potential drawbacks and consult a SEBI-registered financial advisor before making any investment decisions.

What is FX Multitech IPO GMP today?

Grey Market Premium (GMP) for the FX Multitech IPO is an unofficial indicator of market sentiment and potential listing gains. While specific GMP figures fluctuate and are not provided in the official data, it's important to remember that GMP is speculative. Investors should not rely solely on GMP for investment decisions, as it's not regulated and can change rapidly.

Always prioritize fundamental analysis and official IPO details.

How to apply for FX Multitech IPO?

You can apply for the FX Multitech IPO through the ASBA (Application Supported by Blocked Amount) facility via your bank account or through your stockbroker's platform. Most brokers offer online application through their websites or mobile apps, allowing you to bid using your UPI ID. Your funds will remain blocked until the allotment process is complete.

Disclaimer: IPO GMP (Grey Market Premium) is unofficial data and for informational purposes only. It represents market sentiment, not guaranteed listing prices. Always consult a SEBI-registered financial advisor before investing.